Jason Liu Profile - Credit Suisse Analyst
4 Followers
Jason Liu Credit Suisse
Wall Street Analyst
Success Rate
0 out of 7 ratings made a profit
Average Return
-47.40%
Average return per rating
Time Frame
Compare to
Copying Jason Liu's trades since 2021 and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -47.4% per rating.
Stock Rating Distribution
87.50% Buy
12.50% Hold
0.00% Sell
Distribution of Jason Liu's ratings
Additional Information
Main Sector:General
Geo Coverage:
Best Rating
Stock:
New Frontier Health Corporation
(NFH)
(NFH)
Rating:Hold
Date:Apr 08, 2021 - Apr 08, 2022
Return:0.00%
The most profitable rating made by Jason Liu
Jason Liu's Stock Coverage
The United Laboratories International Holdings
Aug 31, 2021
Buy
Reiterated
HK$6.80
(-17.78% Downside)
2Ratings
-25.45%
Jinxin Fertility Group Ltd.
Apr 04, 2023
Buy
Reiterated
HK$7.50
(269.46% Upside)
3Ratings
-55.53%
MicroPort CardioFlow Medtech Corp.
Apr 17, 2023
Buy
Reiterated
HK$3.20
(166.67% Upside)
1Ratings
-61.90%
Venus Medtech (Hangzhou), Inc. Class H
Apr 17, 2023
Buy
Reiterated
HK$16.00
(1112.12% Upside)
1Ratings
-52.90%
List of latest recommendations made by Jason Liu. Click to expand and see Jason Liu's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >About Analyst Ratings
About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
Jason Liu activity FAQ
What is the performance of Jason Liu's recommendations?
The percentage of profitable recommendations made by Jason Liu is 0%, and the average return per transaction is -47.40%.
What was Jason Liu's most profitable rating?
Jason Liu’s most profitable ratings was a hold on NFH stock on Apr 08, 2021 - Apr 08, 2022. The return on the trade was 0.00%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here